Abattis Pharmaceuticals Private Limited

Abattis Pharmaceuticals Private Limited - trading in Ranchi, Jharkhand, India. FY 2026 financials & compliance.
CIN U24290JH2016PTC009043 Incorporated 05 August 2016 ROC Ranchi HQ Ranchi, Jharkhand, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2024
₹2.36 Lakh
▲ 19% YoY
Net loss · FY 2024
₹13.41 Lakh
Latest filing
EBITDA · FY 2024
-₹13.41 Lakh
Latest filing
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings

About Abattis Pharmaceuticals Private Limited

Data last updated:

Abattis Pharmaceuticals Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 05 August 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U24290JH2016PTC009043. Its GSTIN is 20AAOCA8891Q1ZU (Jharkhand).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Saroj Singh and Shiv Kumar Sahu.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Cd/32/2 Sector – 2 Hec Colony Dhurwa Po : Dhurwa, Ranchi, Jharkhand, India – 834004.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.36 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net loss of ₹13.41 Lakh and EBITDA of -₹13.41 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 8% over five years.

As per MCA filings, the company has open charges of ₹10 Lakh on record.

Abattis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-20-0039504). The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Abattis Pharmaceuticals Private Limited
CIN U24290JH2016PTC009043
Registration Number 009043
Incorporation Date 05 August 2016
ROC Ranchi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-JH-20-0039504
Key People
Saroj Singh Director Shiv Kumar Sahu Director

Recognitions & Rankings of Abattis Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-JH-20-0039504
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Cd/32/2 Sector – 2 Hec Colony Dhurwa Po : Dhurwa, Ranchi, Jharkhand, India – 834004
  • Industry
    Trading, Retailers, Retail Trading
Comprehensive company report
Abattis Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Abattis Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Abattis Pharmaceuticals Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Business Activity of Abattis Pharmaceuticals Private Limited

The main business activity of Abattis Pharmaceuticals is trade. In detail, this covers retail trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG2Retail TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Abattis Pharmaceuticals Private Limited FY 2024 filings available

Abattis Pharmaceuticals Private Limited reported revenue of ₹2.36 Lakh (up 19% YoY) for FY 2024.

Revenue · FY 2024
₹2.36 Lakh ▲ 19%
Net loss · FY 2024
₹13.41 Lakh
EBITDA · FY 2024
-₹13.41 Lakh

Compounded Annual Growth Rate (CAGR) of Abattis Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▼ 5%
5 years · compounded
▼ 8%
EBITDA CAGR growth
3 years · compounded
▼ 273%
5 years · compounded
▼ 143%

Revenue rose 19% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Abattis Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹13.41 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹13.41 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Abattis Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin••••••••••••••••••••
Net Profit Margin••••••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Abattis Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Abattis Pharmaceuticals Private Limited

Abattis Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Saroj SinghDirector05 Aug 201610 Years 2 MonthsCurrent
Shiv Kumar SahuDirector20 Aug 20179 Years 2 MonthsCurrent
View all directors

Peer Comparison of Abattis Pharmaceuticals Private Limited

Abattis Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Evoluent Pharmaceuticals Private Limited₹2.41 Lakh (FY 2021)••••••••-55.0%••••Palace Guttahalli, Karnataka, India
Omish Pharmaceuticals Private Limited₹2.41 Lakh (FY 2023)••••••••-93.0%••••Delhi, India
Vardhman Pharmaceuticals Private Limited₹2.39 Lakh (FY 2025)••••••••-8.0%••••Uttar Pradesh, India
DVS Pharmaceuticals (OPC) Private Limited₹2.38 Lakh (FY 2025)••••••••-66.0%••••Etah, Uttar Pradesh, India
Life Plus Pharmaceuticals Private Limited₹2.38 Lakh (FY 2021)••••••••••••Mumbai, Maharashtra, India
Abattis Pharmaceuticals Private Limited this company₹2.36 Lakh (FY 2024)••••••••19.0%••••Ranchi, Jharkhand, India
Medwill Pharmaceuticals Private Limited₹2.36 Lakh (FY 2016)••••••••••••Satara, Maharashtra, India
Yesaswani Pharmaceuticals Private Limited₹2.35 Lakh (FY 2024)••••••••25.0%••••Delhi, India
Rangoli Pharmaceuticals Private Limited₹2.34 Lakh (FY 2024)••••••••••••Noida, Uttar Pradesh, India
Dhara Pharmaceuticals Private Limited₹2.34 Lakh (FY 2018)••••••••••••Fatapukur, West Bengal, India
Cestrum Pharmaceuticals Private Limited₹2.33 Lakh (FY 2019)••••••••••••Pune, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Abattis Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Abattis Pharmaceuticals Private Limited

Abattis Pharmaceuticals Private Limited is audited by BANKA&CO.CHARTERED ACCOUNTANTS for the financial year 2017.

NameStatusAppointment DateCessation Date
BANKA&CO.CHARTERED ACCOUNTANTSLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Abattis Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Abattis Pharmaceuticals Private Limited

Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Canara Bank₹0.10 Cr
Latest charge details
DateLenderAmountStatus
15 Apr 2023Canara Bank₹10 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Abattis Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Abattis Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Abattis Pharmaceuticals Private Limited

Abattis Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Prabhat Ranjan ceased to be Director on 20 Mar 2020.

AGM
Abattis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Abattis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ranchi.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Lakh with Charge ID 100716021 was registered on 15 Apr 2023.
Ceased
Prabhat Ranjan ceased to be Director.
Appointed
Shiv Kumar Sahu was appointed as Director.
Appointed
Saroj Singh was appointed as Director.
Incorporation
05 Aug 2016
Abattis Pharmaceuticals Private Limited was registered on 05 Aug 2016 with Roc Ranchi & aged 10 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Abattis Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Abattis Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Abattis Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Abattis Pharmaceuticals Private Limited

Abattis Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
20AAOCA8891Q1ZUJharkhandActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Abattis Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abattis Pharmaceuticals Private Limited

Abattis Pharmaceuticals is an active private limited company based in Ranchi, Jharkhand, India. The company works in retailers, within the trading industry. It was incorporated on 05 August 2016 (10+ years old) and is registered under CIN U24290JH2016PTC009043.

Abattis Pharmaceuticals reported revenue of ₹2.36 Lakh for FY 2024 (up 19% YoY).

Abattis Pharmaceuticals has 2 current directors:

Abattis Pharmaceuticals reported a net loss of ₹13.41 Lakh and EBITDA of -₹13.41 Lakh for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Abattis Pharmaceuticals is -5% over three years and -8% over five years. In the latest year (FY 2024) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Abattis Pharmaceuticals is 20AAOCA8891Q1ZU, registered in Jharkhand.

The CIN (Corporate Identification Number) of Abattis Pharmaceuticals is U24290JH2016PTC009043. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Abattis Pharmaceuticals was incorporated on 05 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ranchi.

The peers of Abattis Pharmaceuticals by revenue are Evoluent Pharmaceuticals Private Limited, Omish Pharmaceuticals Private Limited, Vardhman Pharmaceuticals Private Limited, DVS Pharmaceuticals (OPC) Private Limited, Life Plus Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Prabhat Ranjan ceased to be Director on 20 Mar 2020. Shiv Kumar Sahu was appointed as Director on 20 Aug 2017. Saroj Singh was appointed as Director on 05 Aug 2016.

Yes, Abattis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-20-0039504).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available